PER

2.44%

8.0¢ percheron therapeutics limited

Ann: ANP Updates on US Regulatory Plans for ATL1102 in DMD, page-145

First 145 Last

Share
Profile

Follow
BP1950

245 Posts.

32

14/08/21

17:16

Post #: 55289939
Share

Originally posted by imperatore: ↑

Some food for thought:
- hold up since 2017 nothing done about it in 4 years.
- meeting with FDA unprepared as hold up always been there hanging over heads.
- apparently hold up was not mentioned during meeting even just for matter of enquire and/or if could
eventually be a problem…….very professional.
- FTD application sent and in my view without proper home work done……very professional
Mr. Diamond.
- After hinting from any corners of the world FTD was a given suddenly application withdrawn due to
hold up in dosing (remember it was there since 2017) and to be reapplied…..by when? In real time not
Diamond’s alleged deadlines.
- Latest announcement is as clear as mud (someone would say) and the Diamond instead of clarifying in
more understandable words let Dr. Gittleson to have a short sugar comment or an accountant that
instead of answering he redirect to the broker Morgan comments.
- As AKKI points out FTD has been granted to numerous bio products with less alleged “outstanding”
results but not to ATL1102……mystery.
I know that several posters think the Diamond is the best thing has happened to ANP but from the above
I really question his knowledge in scientific matters and by now since in my view time is running out also his ability to find funding. In other words it is imperative that Diamond comes out, put his face and give the share holders community some clear explanation (financial as well other application always mentioned but..?) and not the usual mmmm, hum, etc etc.
Will he do it or will keep hiding and buy time?

P.S. ITSA I don’t have any hidden agenda just ask the leader to do his job properly if he is able to otherwise move over.

Expand

I think you are correct. We should not be in this situation. It is an own goal. Hopefully the science will win through. But poor management slows the process.

ANP Price at posting: 17.0¢ Sentiment: Hold Disclosure: Held
5 Upvote

1 Great analysis

Reply

Top Stories

Week 33 Wrap: US recession fears forgotten; RBNZ’s surprise rate cut; more iron ore trouble

WNX

Wellnex sees first special access scheme prescriptions for new Wellness Life brand

Bitcoin: Current State of Play & Where to Next | Swyftx

M2R

EIS co-funded campaign sees Miramar kick off maiden drilling at Bangemall, Gascoyne WA

Emerald & Azure score Digger & Dealer awards

ARD

Argent begins search for VMS mineralisation at Kempfield Cu-Pb-Zn-Au-Ag play in NSW

SVL

Court of Appeal upholds environmental group's challenge to Silver Mines Ltd's Bowden project

IMD

IMDEX to receive $10M in out-of-court settlement with Boart Longyear over downhole tool patent

EQR

EQ Resources transitions historic Mt Carbine tungsten mine to owner-operator system

VTM

Victory Metals dips -8% even as company set to grow heavy REE resource at North Stanmore

There are more pages in this discussion • 30 more messages in this thread...

First 145 Last

Add PER (ASX) to my watchlist

(20min delay)
Last 8.0¢		Change -0.002(2.44%)		Mkt cap ! $72.12M

Open	High	Low	Value	Volume
8.3¢	8.4¢	8.0¢	$58.49K	703.3K

Buyers (Bids)

No.	Vol.	Price($)
2	127624	8.0¢

Sellers (Offers)

Price($)	Vol.	No.
8.4¢	25545	1

View Market Depth

No.	Vol.	Price($)
2	127624	0.080
1	3600	0.079
1	10000	0.077
3	86800	0.075
3	180866	0.074

Price($)	Vol.	No.
0.084	25545	1
0.085	363000	2
0.086	480000	3
0.087	400000	1
0.088	406000	2

Last trade - 16.10pm 16/08/2024 (20 minute delay)

PER (ASX) Chart

Ann: ANP Updates on US Regulatory Plans for ATL1102 in DMD, page-145

Week 33 Wrap: US recession fears forgotten; RBNZ’s surprise rate cut; more iron ore trouble

Wellnex sees first special access scheme prescriptions for new Wellness Life brand

Bitcoin: Current State of Play & Where to Next | Swyftx

EIS co-funded campaign sees Miramar kick off maiden drilling at Bangemall, Gascoyne WA

Emerald & Azure score Digger & Dealer awards

Argent begins search for VMS mineralisation at Kempfield Cu-Pb-Zn-Au-Ag play in NSW

Court of Appeal upholds environmental group's challenge to Silver Mines Ltd's Bowden project

IMDEX to receive $10M in out-of-court settlement with Boart Longyear over downhole tool patent

EQ Resources transitions historic Mt Carbine tungsten mine to owner-operator system

Victory Metals dips -8% even as company set to grow heavy REE resource at North Stanmore

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: ANP Updates on US Regulatory Plans for ATL1102 in DMD, page-145

Top Stories

Week 33 Wrap: US recession fears forgotten; RBNZ’s surprise rate cut; more iron ore trouble

Wellnex sees first special access scheme prescriptions for new Wellness Life brand

Bitcoin: Current State of Play & Where to Next | Swyftx

EIS co-funded campaign sees Miramar kick off maiden drilling at Bangemall, Gascoyne WA

Emerald & Azure score Digger & Dealer awards

Argent begins search for VMS mineralisation at Kempfield Cu-Pb-Zn-Au-Ag play in NSW

Court of Appeal upholds environmental group's challenge to Silver Mines Ltd's Bowden project

IMDEX to receive $10M in out-of-court settlement with Boart Longyear over downhole tool patent

EQ Resources transitions historic Mt Carbine tungsten mine to owner-operator system

Victory Metals dips -8% even as company set to grow heavy REE resource at North Stanmore

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News